Strong private equity investment and strategic M&A in 2024, and a shift toward clinical-stage companies and asset-driven ...

Senti Bio aims to improve cancer therapeutics with customizable gene circuits, or multi-gene constructs capable of ...

Experts at Crowe Life Sciences offer tips for effectively managing risk associated with third parties such as clinics, retail ...

Simon-Kucher's industry study reveals barriers and success factors for improving global pricing and marketing access ...

Evaluate VP of Thought Leadership Daniel Chancellor discusses trends for 2025 as the surge in R&D, coupled with rapidly ...

Greenphire’s network of over 90 Concierge Coordinators across 40+ countries provides personalized travel and logistical support to clinical trial participants, ensuring patient comfort and engagement ...

Historically, site payments have been plagued by inefficiencies such as delays, lack of transparency, and errors in contract updates. Greenphire’s Senior Product Manager, Iain Wood, utilized his ...

Managing clinical trial disclosures can be tedious and error-prone, opening the door to noncompliance. TrialScope Disclose provides a better way. Our centralized platform automates data entry and ...

Artificial intelligence (AI) continues to disrupt existing paradigms in drug development, with early adopters experiencing both the benefits and challenges of this innovative technology. With that in ...

Terran Biosciences' founder and CEO Sam Clark talks about big opportunities for prodrug development in 2025, the importance of a strong medicinal chemistry team, and a potential increase in M&A ...